NEW YORK, March 15 – Nanogen said Thursday it had shipped a new system designed for targeted gene expression applications for beta testing at two undisclosed US institutions and one in Europe.

Nanogen plans to use the results of the tests to develop new applications for detecting gene expression. Currently the company’s NanoChip system is primarily used do detect and analyze SNPs, short tandem repeats, and mutations.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.